Integer Holdings Corp (ITGR)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES

5830 GRANITE PARKWAY., SUITE 1150 PLANO, TX 75024

GreatBatch operates its business in two reportable segments: Greatbatch Medical and Electrochem Solutions (Electrochem). The Greatbatch Medical segment designs and manufactures medical devices and components primarily for the Cardiac Rhythm Management, Neuromodulation, Vascular Access and Orthopaedic markets. Additionally, Greatbatch Medical provides assembly and designs engineering services for products that incorporate Greatbatch Medical components. Co.'s Electrochem segment designs, manufactures and distributes primary and rechargeable batteries, battery packs and wireless sensors for applications in energy, security, portable medical, and environmental monitoring markets.

Data as of 2020-08-01
Market Cap2.159 Billion Shares Outstanding32.834 Million Avg 30-day Volume238.442 Thousand
P/E Ratio21.3 Dividend Yield EPS3.2
Price/Sales2.255 Price cash flow ratio12.1 Price free cash flow ratio38.1
Book Value35.46 Price to Tangible Book-5.07 Alpha0.0
Short Interest Ratio2.64 % Short Interest to Float1.8 R-squared0.207256
BETA1.33007 52-week High/Low99.95 / 46.01 Stddev0.125701

Are you looking for this stock instead?

View SEC Filings from ITGR instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 1 (0.07%)
13F Filers holding this stock: 214 64 (4.19%)
Aggregate 13F shares on 03/31/2020: 32.14 Million 14.005 Million
Aggregate 13F shares on 12/31/2019: 32.375 Million 12.178 Million
Percent change: -0.72% 15.00%
Funds creating new positions: 24 11
Funds Adding to an existing position: 72 18
Funds closing out their position: 37 17
Funds reducing their position: 91 30
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ITGR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ITGR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

5.3 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BIHL ANTHONY P III

  • Director
0 2020-07-28 0

SODERBERG PETER H

  • Director
252,082 2020-06-30 3

FLANAGAN JOSEPH F EVP, QUALITY & REGULATORY AFFA

  • Officer
9,971 2020-06-08 3

HINRICHS JAMES F.

  • Director
50,514 2020-06-08 2

BAILEY PAMELA G

  • Director
49,544 2020-05-20 3

SUMMERS WILLIAM B JR

  • Director
45,410 2020-05-20 3

SANFORD BILL R

  • Director
68,409 2020-05-20 2

HOBBY JEAN M.

  • Director
12,833 2020-05-20 3

MAXWELL MARTIN C

  • Director
17,533 2020-05-20 2

PASSERINI FILIPPO

  • Director
12,833 2020-05-20 2

SPENCE DONALD J

  • Director
18,781 2020-05-20 3

HOUGHTON CARTER PRESIDENT, ELECTROCHEM

  • Officer
2,395 2020-05-13 2

TRECKER KRISTIN SENIOR VICE PRESIDENT & CHRO

  • Officer
440 2020-05-07 0

DINKINS MICHAEL

  • Director
0 2020-04-27 0

BECKER JOEL PRESIDENT, CRM & NEURO

  • Officer
382 2020-04-22 2

BOLT JENNIFER M SVP, GLOBAL OPERATIONS

  • Officer
22,107 2020-04-01 3

HOOK THOMAS J

  • Director
9,057 2020-02-13 0

DALL MARCIA A EVP, AND CHIEF FINANCIAL OFFIC

  • Officer
0 2020-02-12 0

DZIEDZIC JOSEPH W PRESIDENT & CEO

  • Officer
  • Director
71,593 2020-01-31 2

THOR KIRK K CHIEF HUMAN RESOURCES OFFICER

  • Officer
4,544 2020-01-31 2

THOMAS TOMMY P VP, CORPORATE CONTROLLER

  • Officer
559 2020-01-31 2

KHALES PAYMAN PRESIDENT, C&V

  • Officer
1,303 2020-01-31 2

GARLAND JASON K EVP, CHIEF FINANCIAL OFFICER

  • Officer
2,569 2020-01-31 3

BOROWICZ ANTHONY W SVP STRATEGY,CORP DEV., IR

  • Officer
23,323 2020-01-31 2

GIDDENS ELIZABETH SVP, GENERAL COUNSEL

  • Officer
0 2020-01-31 3

GRAHAM MICHELLE CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2020-01-21 0

MILLER JOSEPH A

  • Director
0 2020-01-14 0

BENEDETTI MARCO

  • Director
17,416 2019-11-18 0

WAREHAM JOHN P

  • Director
11,300 2019-11-01 0

GONZALEZ JOSE ANTONIO PRESIDENT, CRM & NEURO

  • Officer
5,847 2019-02-28 0

SPENCER MICHAEL L CHIEF ETHICS & COMPLIANCE OF

  • Officer
7,962 2019-02-28 0

MCEVOY TIMOTHY G SR. VP, GEN. COUNSEL & SEC.

  • Officer
35,453 2018-12-28 0

FRIEDMAN JEREMY EVP, COO

  • Officer
16,514 2018-12-28 0

SMYTH DECLAN PRES., ADVANCED SURGICAL, ORTH

  • Officer
6,766 2018-05-16 0

HAIRE GARY J EVP & CHIEF FINANCIAL OFFICER

  • Officer
4,411 2018-05-16 0

MAZZA THOMAS J VP, CORPORATE CONTROLLER

  • Officer
6,748 2018-01-03 0

HARRIS JOHN A INTERIM PRESIDENT, C&V

  • Officer
1,136 2017-12-29 0

MAZZOCCHI RUDY A

  • Director
51,948 2017-07-25 0

HICKMAN THOMAS KELLEY EVP, SALES & MARKETING

  • Officer
No longer subject to file 2017-07-25 0

ARELLANO MAURICIO EVP, GLOBAL OPERATIONS

  • Officer
42,213 2016-01-15 0

HOLMAN ANDREW P EVP, GLOBAL SALES & MARKETING

  • Officer
8,107 2016-01-15 0

VOBORIL EDWARD F

  • Director
15,631 2015-02-02 0

CINTRA GEORGE M EXEC. VP, CTO

  • Officer
6,989 2015-01-20 0

MELIA KEVIN C

  • Director
54,375 2014-06-15 0

BRATTON SUSAN M EVP, BUSINESS DEVELOPMENT

  • Officer
59,892 2013-06-11 0

KAISER DANIEL ROBERT CHIEF TECHNOLOGY OFFICER

  • Officer
336 2012-12-31 0

WISNIEWSKI HELENA S.

  • Director
9,610 2012-01-01 0

AMERICAN MEDICAL SYSTEMS HOLDINGS INC

  • Director
0 2011-10-13 0

CAMPBELL SUSAN H SR. VP, ORTHOPAEDICS

  • Officer
0 2010-03-10 0

DAVIS BARBARA M VICE PRESIDENT, HUMAN RESOURCE

  • Officer
13,436 2010-01-01 0

FARRELL RICHARD M. VP, QIG GROUP

  • Officer
No longer subject to file 2010-01-01 0

AYLIFFE JOHN VP EUROPE

  • Officer
13,727 2008-09-11 0

SUMMER THOMAS S

  • Director
No longer subject to file 2008-05-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FLANAGAN JOSEPH F - Officer EVP, QUALITY & REGULATORY AFFA

2020-06-08 S 5,308 $85.18 d 9,971 9,971.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments